Antibodies against venom of the snake Deinagkistrodon acutus

Applied and Environmental Microbiology

Volumn 82, Issue 1, 2016, Pages 71-80

  Lee, Chi Hsin ^a   Lee, Yu Ching ^b   Liang, Meng Huei ^b   Leu, Sy Jye ^a,c   Lin, Liang Tzung ^a,c   Chiang, Jen Ron ^d   Yang, Yi Yuan ^b,e  

^a TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^b TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^c TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^d CENTER FOR DISEASE CONTROL   (Taiwan)

^e TAIPEI MEDICAL UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

CLONING; MASS SPECTROMETRY; PROTEINS;

DIAGNOSTIC AGENTS; ENZYME LINKED IMMUNOSORBENT ASSAY; LETHAL EFFECTS; METALLOPROTEINASES; NUCLEOTIDE SEQUENCES; PHAGE DISPLAY TECHNOLOGY; SINGLE CHAIN VARIABLE FRAGMENTS; WESTERN BLOTTING;

ANTIBODIES;

ANTIBODY; ASSAY; PROTEIN; SNAKE; VENOM;

DEINAGKISTRODON ACUTUS; EQUIDAE; MUS;

REPTILIAN PROTEIN; SINGLE CHAIN FRAGMENT VARIABLE ANTIBODY; SNAKE VENOM;

AMINO ACID SEQUENCE; ANIMAL; ANTIBODY SPECIFICITY; CHEMISTRY; CHICK EMBRYO; FEMALE; GENETICS; IMMUNOLOGY; INSTITUTE FOR CANCER RESEARCH MOUSE; MOLECULAR GENETICS; MOUSE; SEQUENCE ALIGNMENT; VIPERIDAE;

AMINO ACID SEQUENCE; ANIMALS; ANTIBODY SPECIFICITY; CHICK EMBRYO; FEMALE; MICE; MICE, INBRED ICR; MOLECULAR SEQUENCE DATA; REPTILIAN PROTEINS; SEQUENCE ALIGNMENT; SINGLE-CHAIN ANTIBODIES; SNAKE VENOMS; VIPERIDAE;

EID: 84953931680     PISSN: 00992240     EISSN: 10985336     Source Type: Journal    
DOI: 10.1128/AEM.02608-15     Document Type: Article

References (53)

1. Sajevic T, Leonardi A, Krizaj I. 2011. Haemostatically active proteins in snake venoms. Toxicon 57:627-645. http://dx.doi.org/10.1016/j.toxicon.2011.01.006.
2. Aird SD. 2002. Ophidian envenomation strategies and the role of purines. Toxicon 40:335-393. http://dx.doi.org/10.1016/S0041-0101(01)00232-X.
3. Ming-Yi L, Ruey-Jen H. 1997. Toxoids and antivenoms of venomous snakes in Taiwan. J Toxicol Toxin Rev 16:163-175. http://dx.doi.org/10.3109/15569549709016453.
4. Xu X, Zhang L, Luo Z, Shen D, Wu H, Peng L, Song J, Zhang Y. 2010. Metal ions binding to NAD-glycohydrolase from the venom of Agkistrodon acutus: regulation of multicatalytic activity. Metallomics 2:480-489. http://dx.doi.org/10.1039/c0mt00017e.
5. Ouyang C, Teng CM, Huang TF. 1990. Characterization of snake venom principles affecting blood coagulation and platelet aggregation. Adv Exp Med Biol 281:151-163. http://dx.doi.org/10.1007/978-1-4615-3806-6_15.
6. Tu AT. 1996. Overview of snake venom chemistry. Adv Exp Med Biol 391:37-62. http://dx.doi.org/10.1007/978-1-4613-0361-9_3.
7. Ouyang C, Teng CM, Huang TF. 1982. Characterization of the purified principles of Formosan snake venoms which affect blood coagulation and platelet aggregation. Taiwan Yi Xue Hui Za Zhi 81:781-790.
8. Markland FS, Jr, Swenson S. 2013. Snake venom metalloproteinases. Toxicon 62:3-18. http://dx.doi.org/10.1016/j.toxicon.2012.09.004.
9. Gold BS, Dart RC, Barish RA. 2002. Bites of venomous snakes. N Engl J Med 347:347-356. http://dx.doi.org/10.1056/NEJMra013477.
10. Warr GW, Magor KE, Higgins DA. 1995. IgY: clues to the origins of modern antibodies. Immunol Today 16:392-398. http://dx.doi.org/10.1016/0167-5699(95)80008-5.
11. Gassmann M, Thommes P, Weiser T, Hubscher U. 1990. Efficient production of chicken egg yolk antibodies against a conserved mammalian protein. FASEB J 4:2528-2532.
12. Hatta H, Tsuda K, Akachi S, Kim M, Yamamoto T. 1993. Productivity and some properties of egg yolk antibody (IgY) against human rotavirus compared with rabbit IgG. Biosci Biotechnol Biochem 57:450-454. http://dx.doi.org/10.1271/bbb.57.450.
13. Hatta H, Kim M, Yamamoto T. 1990. A novel isolation method for hen egg yolk antibody, "IgY." Agric Biol Chem 54:2531-2535.
14. Schade R, Burger W, Schoneberg T, Schniering A, Schwarzkopf C, Hlinak A, Kobilke H. 1994. Avian egg yolk antibodies. The egg laying capacity of hens following immunisation with antigens of different kind and origin and the efficiency of egg yolk antibodies in comparison to mammalian antibodies. ALTEX 11:75-84.
15. Mine Y, Kovacs-Nolan J. 2002. Chicken egg yolk antibodies as therapeutics in enteric infectious disease: a review. J Med Food 5:159-169. http://dx.doi.org/10.1089/10966200260398198.
16. Kruger C, Pearson SK, Kodama Y, Vacca Smith A, Bowen WH, Hammarstrom L. 2004. The effects of egg-derived antibodies to glucosyltransferases on dental caries in rats. Caries Res 38:9-14. http://dx.doi.org/10.1159/000073914.
17. Kovacs-Nolan J, Mine Y. 2012. Egg yolk antibodies for passive immunity. Annu Rev Food Sci Technol 3:163-182. http://dx.doi.org/10.1146/annurev-food-022811-101137.
18. Nilsson E, Kollberg H, Johannesson M, Wejaker PE, Carlander D, Larsson A. 2007. More than 10 years' continuous oral treatment with specific immunoglobulin Y for the prevention of Pseudomonas aeruginosa infections: a case report. J Med Food 10:375-378. http://dx.doi.org/10.1089/jmf.2006.214.
19. Nilsson E, Larsson A, Olesen HV, Wejaker PE, Kollberg H. 2008. Good effect of IgY against Pseudomonas aeruginosa infections in cystic fibrosis patients. Pediatr Pulmonol 43:892-899. http://dx.doi.org/10.1002/ppul.20875.
20. Yokoyama K, Sugano N, Shimada T, Shofiqur RA, el Ibrahim SM, Isoda R, Umeda K, Sa NV, Kodama Y, Ito K. 2007. Effects of egg yolk antibody against Porphyromonas gingivalis gingipains in periodontitis patients. J Oral Sci 49:201-206. http://dx.doi.org/10.2334/josnusd.49.201.
21. Smith GP. 1985. Filamentous fusion phage: novel expression vectors that display cloned antigens on the virion surface. Science 228:1315-1317. http://dx.doi.org/10.1126/science.4001944.
22. Barbas CF, III, Kang AS, Lerner RA, Benkovic SJ. 1991. Assembly of combinatorial antibody libraries on phage surfaces: the gene III site. Proc Natl Acad Sci U S A 88:7978-7982. http://dx.doi.org/10.1073/pnas.88.18.7978.
23. Chi XS, Landt Y, Crimmins DL, Dieckgraefe BK, Ladenson JH. 2002. Isolation and characterization of rabbit single chain antibodies to human Reg Ialpha protein. J Immunol Methods 266:197-207. http://dx.doi.org/10.1016/S0022-1759(02)00117-5.
24. Park KJ, Park DW, Kim CH, Han BK, Park TS, Han JY, Lillehoj HS, Kim JK. 2005. Development and characterization of a recombinant chicken single-chain Fv antibody detecting Eimeria acervulina sporozoite antigen. Biotechnol Lett 27:289-295. http://dx.doi.org/10.1007/s10529-005-0682-8.
25. Pavoni E, Flego M, Dupuis ML, Barca S, Petronzelli F, Anastasi AM, D'Alessio V, Pelliccia A, Vaccaro P, Monteriu G, Ascione A, De Santis R, Felici F, Cianfriglia M, Minenkova O. 2006. Selection, affinity maturation, and characterization of a human scFv antibody against CEA protein. BMC Cancer 6:41. http://dx.doi.org/10.1186/1471-2407-6-41.
26. Fehrsen J, van Wyngaardt W, Mashau C, Potgieter AC, Chaudhary VK, Gupta A, Jordaan FA, du Plessis DH. 2005. Serogroup-reactive and type-specific detection of bluetongue virus antibodies using chicken scFvs in inhibition ELISAs. J Virol Methods 129:31-39. http://dx.doi.org/10.1016/j.jviromet.2005.04.015.
27. Finlay WJ, Shaw I, Reilly JP, Kane M. 2006. Generation of high-affinity chicken single-chain Fv antibody fragments for measurement of the Pseudonitzschia pungens toxin domoic acid. Appl Environ Microbiol 72: 3343-3349. http://dx.doi.org/10.1128/AEM.72.5.3343-3349.2006.
28. Huston JS, Levinson D, Mudgett-Hunter M, Tai MS, Novotny J, Margolies MN, Ridge RJ, Bruccoleri RE, Haber E, Crea R. 1988. Protein engineering of antibody binding sites: recovery of specific activity in an anti-digoxin single-chain Fv analogue produced in Escherichia coli. Proc Natl Acad Sci U S A 85:5879-5883. http://dx.doi.org/10.1073/pnas.85.16.5879.
29. Holliger P, Hudson PJ. 2005. Engineered antibody fragments and the rise of single domains. Nat Biotechnol 23:1126-1136. http://dx.doi.org/10.1038/nbt1142.
30. Kulkeaw K, Sakolvaree Y, Srimanote P, Tongtawe P, Maneewatch S, Sookrung N, Tungtrongchitr A, Tapchaisri P, Kurazono H, Chaicumpa W. 2009. Human monoclonal ScFv neutralize lethal Thai cobra, Naja kaouthia, neurotoxin. J Proteomics 72:270-282. http://dx.doi.org/10.1016/j.jprot.2008.12.007.
31. Akita EM, Nakai S. 1993. Comparison of four purification methods for the production of immunoglobulins from eggs laid by hens immunized with an enterotoxigenic E. coli strain. J Immunol Methods 160:207-214. http://dx.doi.org/10.1016/0022-1759(93)90179-B.
32. Akita EM, Nakai S. 1993. Production and purification of Fab' fragments from chicken egg yolk immunoglobulin Y (IgY). J Immunol Methods 162:155-164. http://dx.doi.org/10.1016/0022-1759(93)90380-P.
33. Andris-Widhopf J, Rader C, Steinberger P, Fuller R, Barbas CF, III. 2000. Methods for the generation of chicken monoclonal antibody fragments by phage display. J Immunol Methods 242:159-181. http://dx.doi.org/10.1016/S0022-1759(00)00221-0.
34. Yamanaka HI, Inoue T, Ikeda-Tanaka O. 1996. Chicken monoclonal antibody isolated by a phage display system. J Immunol 157:1156-1162.
35. Meier J, Stocker KF. 1995. Biology and distribution of venomous snakes of medical importance and the composition of snake venoms, p 367-412. In White J, Meier J (ed), Handbook of clinical toxicology of animal venoms and poisons. CRC Press, Boca Raton, FL.
36. Dias da Silva W, Tambourgi DV. 2010. IgY: a promising antibody for use in immunodiagnostic and in immunotherapy. Vet Immunol Immunopathol 135:173-180. http://dx.doi.org/10.1016/j.vetimm.2009.12.011.
37. Davalos-Pantoja L, Ortega-Vinuesa JL, Bastos-Gonzalez D, Hidalgo-Alvarez R. 2000. A comparative study between the adsorption of IgY and IgG on latex particles. J Biomater Sci Polym Ed 11:657-673. http://dx.doi.org/10.1163/156856200743931.
38. Carlander D, Larsson A. 2001. Avian antibodies can eliminate interference due to complement activation in ELISA. Ups J Med Sci 106:189-195. http://dx.doi.org/10.3109/2000-1967-145.
39. Stewart CS, MacKenzie CR, Hall JC. 2007. Isolation, characterization and pentamerization of alpha-cobrotoxin specific single-domain antibodies from a naive phage display library: preliminary findings for antivenom development. Toxicon 49:699-709. http://dx.doi.org/10.1016/j.toxicon.2006.11.023.
40. Maynard J, Georgiou G. 2000. Antibody engineering. Annu Rev Biomed Eng 2:339-376. http://dx.doi.org/10.1146/annurev.bioeng.2.1.339.
41. Gao C, Mao S, Kaufmann G, Wirsching P, Lerner RA, Janda KD. 2002. Amethod for the generation of combinatorial antibody libraries using pIX phage display. Proc Natl Acad SciUSA99:12612-12616. http://dx.doi.org/10.1073/pnas.192467999.
42. Pandey S. 2010. Hybridoma technology for production of monoclonal antibodies. Hybridoma 1:017.
43. Xu JL, Davis MM. 2000. Diversity in the CDR3 region of V(H) is sufficient for most antibody specificities. Immunity 13:37-45. http://dx.doi.org/10.1016/S1074-7613(00)00006-6.
44. Rucavado A, Escalante T, Shannon JD, Ayala-Castro CN, Villalta M, Gutierrez JM, Fox JW. 2012. Efficacy of IgG and F(ab')2 antivenoms to neutralize snake venom-induced local tissue damage as assessed by the proteomic analysis of wound exudate. J Proteome Res 11:292-305. http://dx.doi.org/10.1021/pr200847q.
45. Rucavado A, Escalante T, Shannon J, Gutierrez JM, Fox JW. 2011. Proteomics of wound exudate in snake venom-induced pathology: search for biomarkers to assess tissue damage and therapeutic success. J Proteome Res 10:1987-2005. http://dx.doi.org/10.1021/pr101208f.
46. Friguet B, Chaffotte AF, Djavadi-Ohaniance L, Goldberg ME. 1985. Measurements of the true affinity constant in solution of antigenantibody complexes by enzyme-linked immunosorbent assay. J Immunol Methods 77:305-319. http://dx.doi.org/10.1016/0022-1759(85)90044-4.
47. Francischetti IM, My-Pham V, Harrison J, Garfield MK, Ribeiro JM. 2004. Bitis gabonica (Gaboon viper) snake venom gland: toward a catalog for the full-length transcripts (cDNA) and proteins. Gene 337:55-69. http://dx.doi.org/10.1016/j.gene.2004.03.024.
48. Fox JW, Serrano SM. 2005. Structural considerations of the snake venom metalloproteinases, key members of the M12 reprolysin family of metalloproteinases. Toxicon 45:969-985. http://dx.doi.org/10.1016/j.toxicon.2005.02.012.
49. Takeda S, Takeya H, Iwanaga S. 2012. Snake venom metalloproteinases: structure, function and relevance to the mammalian ADAM/ADAMTS family proteins. Biochim Biophys Acta 1824:164-176. http://dx.doi.org/10.1016/j.bbapap.2011.04.009.
50. Gutierrez JM, Rucavado A, Escalante T, Diaz C. 2005. Hemorrhage induced by snake venom metalloproteinases: biochemical and biophysical mechanisms involved in microvessel damage. Toxicon 45:997-1011. http://dx.doi.org/10.1016/j.toxicon.2005.02.029.
51. Calvete JJ, Marcinkiewicz C, Monleon D, Esteve V, Celda B, Juarez P, Sanz L. 2005. Snake venom disintegrins: evolution of structure and function. Toxicon 45:1063-1074. http://dx.doi.org/10.1016/j.toxicon.2005.02.024.
52. Baldo C, Jamora C, Yamanouye N, Zorn TM, Moura-da-Silva AM. 2010. Mechanisms of vascular damage by hemorrhagic snake venom metalloproteinases: tissue distribution and in situ hydrolysis. PLoS Negl Trop Dis 4:e727. http://dx.doi.org/10.1371/journal.pntd.0000727.
53. Escalante T, Rucavado A, Fox JW, Gutierrez JM. 2011. Key events in microvascular damage induced by snake venom hemorrhagic metalloproteinases. J Proteomics 74:1781-1794. http://dx.doi.org/10.1016/j.jprot.2011.03.026.